Anti-BTLA (tifcemalimab biosimilar) mAb

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
DIM-BME100695.50	50 µg		-	-	7 - 16 business days*		120.00€
DIM-BME100695.100	100 µg		-	-	7 - 16 business days*		237.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Research use only. Protein function: Inhibitory receptor on lymphocytes that negatively regulates... more

Close menu

Product information "Anti-BTLA (tifcemalimab biosimilar) mAb"

Research use only. Protein function: Inhibitory receptor on lymphocytes that negatively regulates antigen receptor signaling via PTPN6/SHP-1 and PTPN11/SHP-2 (PubMed:12796776, PubMed:14652006, PubMed:15568026, PubMed:18193050). May interact in cis (on the same cell) or in trans (on other cells) with TNFRSF14 (PubMed:19915044). In cis interactions, appears to play an immune regulatory role inhibiting in trans interactions in naive T cells to maintain a resting state. In trans interactions, can predominate during adaptive immune response to provide survival signals to effector T cells (PubMed:19915044). [The UniProt Consortium]

Keywords:	Icatolimab,JS-004,JS004,JS 004,JS-4,JS4,JS 4,TAB-004,TAB004,TAB 004,TAB-4,TAB4,TAB 4, Anti-CD272, Anti-B- and T-lymphocyte attenuator, Anti-B- and T-lymphocyte-associated protein
Supplier:	DIMA
Supplier-Nr:	BME100695

Properties

Antibody Type:	Monoclonal
Conjugate:	No
Species reactivity:	human
Format:	Lyophilized

Database Information

KEGG ID :	K06707 \| Matching products
UniProt ID :	Q7Z6A9 \| Matching products
Gene ID :	GeneID 151888 \| Matching products

Handling & Safety

Storage:	-20°C (avoid repeat freezing and thawing cycles)
Shipping:	+20°C (International: +20°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Anti-BTLA (tifcemalimab biosimilar) mAb"

Write a review